ACTINOGEN MEDICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.029 AUD | +3.57% |
|
-6.45% | +31.82% |
| 07/05 | Actinogen Medical Lodges Prospectus for Nearly AU$4 Million Entitlement Offer | MT |
| 03/05 | Actinogen Medical Raising Up to AU$8.9 Million for Advancing Trial, Working Capital; Shares Fall 24% | MT |
Chart calendar Actinogen Medical Limited
159ced8d2c1b4893aff1e481822a64b.fpGLddF0UUyX8DVzz-5bv7m1LBa1Z_mIRbUCflWXkfs.BqPCNpUZBQmviAUkg75jjtTRG3_wVL3fd_RLMh3t_KM61dwwlEEcAuCFBQ~ee8bc1d70a655bfda3f28ee376eff482
Upcoming events on Actinogen Medical Limited
Past events on Actinogen Medical Limited
| 27/03/2024 | ASX Small and Mid Cap Conference |
| 26/02/2024 04:20 am | Q2 2024 Earnings Release |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 07/01/2024 | Sachs Neuroscience Innovation Forum |
| 17/11/2023 04:30 am | Annual General Meeting |
| 15/11/2023 | Bell Potter Healthcare Conference |
| 25/10/2023 | CTAD Conference |
| 17/10/2023 | BIO Investor Forum |
| 06/10/2023 | Dementia Trials Australia Scientific Meeting |
| 29/09/2023 | Asian Society Against Dementia International Congress |
| 31/08/2023 06:30 am | Business Update Call |
| 30/08/2023 02:34 pm | Q4 2023 Earnings Release |
| 11/08/2023 | Rights Issue: 100 new shares @ 0.025 AUD for 454 existing shares |
| 31/07/2023 07:09 am | June 2023 Sales and Revenue Release - Activities Report |
| 25/07/2023 | Bioshares Biotech Summit |
| 17/07/2023 | Alzheimer Association International Conference |
| 06/06/2023 01:30 am | BIO International Convention |
| 24/05/2023 06:30 am | ACW Clinical Trials Science Forum |
| 30/03/2023 | Alzhelmer and Parkinson Diseases Conference |
| 24/02/2023 | Spark Plus Biotech Conference |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 4,86 | 3,61 3,00 20.35% | 0,00 | 3,68 2,50 47.25% | 5,25 4,42 18.83% | 7,70 |
|
EBITDA Million AUD | Released Forecast Spread | -9,05 | -4,89 -7,53 35.11% | 0,00 | -9,09 -7,11 -27.87% | -10,2 -9,00 -13.48% | -16,5 |
|
EBIT Million AUD | Released Forecast Spread | -9,40 | -5,30 -7,89 32.78% | 0,00 | -9,49 -7,51 -26.4% | -10,6 -9,40 -12.96% | -16,1 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -9,89 | -5,33 -7,89 32.41% | 0,00 | -9,50 -7,51 -26.46% | -10,8 -9,40 -14.39% | -16,6 |
|
Net income Million AUD | Released Forecast Spread | -9,89 | -5,33 -7,89 32.41% | -3,92 | -9,50 -7,51 -26.46% | -10,8 -9,40 -14.39% | -16,6 |
|
EPS AUD | Released Forecast Spread | -0,01 | 0,00 -0,01 32.43% | 0,00 | -0,01 -0,01 9.67% | -0,01 -0,01 -18.4% | -0,01 |
| Announcement Date | 16/08/19 | 26/08/20 | 30/08/21 | 25/08/22 | 30/08/23 | - |
Quarterly results
| Fiscal Period | June | 2023 S1 |
|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,14 0,00 - |
|
EBIT Million AUD | Released Forecast Spread | -7,34 -7,00 -4.93% |
|
Net income Million AUD | Released Forecast Spread | -7,44 -7,00 -6.27% |
| Announcement Date | 22/02/23 |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 16/05/2024 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 21/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 22/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 01/07/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Actinogen Medical Limited
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACW Stock
- Calendar Actinogen Medical Limited
